Neurological research · 2025
Utilizing peroneal nerve conduction studies to differentiate L5 radiculopathy and peripheral neuropathies of the lower extremity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fidancı Halit, Alaydın Halil Can
Аннотация
BACKGROUND: L5 radiculopathy, peroneal neuropathy at the fibular head (PNFH), and sciatic neuropathy (SN) often share similar clinical features, such as foot drop. The ability of peroneal nerve conduction studies (NCSs) to distinguish these three conditions was investigated.
METHODS: NCS findings of the patients with L5 radiculopathy, PNFH and SN were reviewed retrospectively. Additionally, needle electromyography (EMG) findings of the tibialis anterior (TA) and peroneus longus (PL) muscles were analyzed.
RESULTS: Sixty-six patients with L5 radiculopathy, 53 patients with PNFH, and 75 patients with SN were included. Fourteen (21.2%) patients with L5 radiculopathy, 14 (26.4%) patients with PNFH, and 57 (76.0%) patients with SN had abnormal superficial peroneal nerve compound nerve action potential (CNAP) amplitude. Superficial peroneal nerve CNAP amplitude abnormalities were significantly more prevalent in SN patients (p < 0.001). Among patients with abnormal superficial peroneal nerve CNAP amplitudes, peroneal nerve compound muscle action potential (CMAP) abnormalities recorded from TA/extensor digitorum brevis were observed in 11/9 L5 radiculopathy patients (p = 0.014/0.002), 6/6 PNFH patients (p = 0.413/0.063), and 48/37 SN patients (p < 0.001/0.001). Needle EMG abnormalities in TA/PL muscles were found in 50(75.8%)/61(92.4%), 53(100%)/34(64.2%), and 51(68.0%)/45(60.0%) of patients with L5 radiculopathy, PNFH, and SN, respectively.
CONCLUSION: This study highlights that, unlike PNFH, superficial peroneal nerve CNAP amplitude abnormalities in L5 radiculopathy and SN are often accompanied by peroneal nerve CMAP amplitude abnormalities.
METHODS: NCS findings of the patients with L5 radiculopathy, PNFH and SN were reviewed retrospectively. Additionally, needle electromyography (EMG) findings of the tibialis anterior (TA) and peroneus longus (PL) muscles were analyzed.
RESULTS: Sixty-six patients with L5 radiculopathy, 53 patients with PNFH, and 75 patients with SN were included. Fourteen (21.2%) patients with L5 radiculopathy, 14 (26.4%) patients with PNFH, and 57 (76.0%) patients with SN had abnormal superficial peroneal nerve compound nerve action potential (CNAP) amplitude. Superficial peroneal nerve CNAP amplitude abnormalities were significantly more prevalent in SN patients (p < 0.001). Among patients with abnormal superficial peroneal nerve CNAP amplitudes, peroneal nerve compound muscle action potential (CMAP) abnormalities recorded from TA/extensor digitorum brevis were observed in 11/9 L5 radiculopathy patients (p = 0.014/0.002), 6/6 PNFH patients (p = 0.413/0.063), and 48/37 SN patients (p < 0.001/0.001). Needle EMG abnormalities in TA/PL muscles were found in 50(75.8%)/61(92.4%), 53(100%)/34(64.2%), and 51(68.0%)/45(60.0%) of patients with L5 radiculopathy, PNFH, and SN, respectively.
CONCLUSION: This study highlights that, unlike PNFH, superficial peroneal nerve CNAP amplitude abnormalities in L5 radiculopathy and SN are often accompanied by peroneal nerve CMAP amplitude abnormalities.